Captrust Financial Advisors Sells 3,974 Shares of Corteva, Inc. (NYSE:CTVA)

Captrust Financial Advisors lessened its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 4.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 88,143 shares of the company's stock after selling 3,974 shares during the quarter. Captrust Financial Advisors' holdings in Corteva were worth $5,021,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in shares of Corteva by 6.7% during the third quarter. JPMorgan Chase & Co. now owns 4,605,608 shares of the company's stock worth $270,764,000 after acquiring an additional 288,885 shares during the last quarter. Nordea Investment Management AB boosted its stake in Corteva by 5.5% in the 4th quarter. Nordea Investment Management AB now owns 60,518 shares of the company's stock worth $3,442,000 after purchasing an additional 3,132 shares in the last quarter. First Hawaiian Bank grew its position in Corteva by 83.7% during the 4th quarter. First Hawaiian Bank now owns 15,737 shares of the company's stock worth $896,000 after purchasing an additional 7,170 shares during the last quarter. Harbor Capital Advisors Inc. increased its stake in Corteva by 2.5% during the 4th quarter. Harbor Capital Advisors Inc. now owns 20,286 shares of the company's stock valued at $1,155,000 after purchasing an additional 497 shares in the last quarter. Finally, Graypoint LLC purchased a new position in shares of Corteva in the fourth quarter worth $203,000. Hedge funds and other institutional investors own 81.54% of the company's stock.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 26,560 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now owns 11,347 shares in the company, valued at approximately $723,257.78. This represents a 70.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.14% of the stock is owned by company insiders.

Corteva Trading Up 1.3 %

Shares of NYSE:CTVA opened at $67.70 on Friday. The business's 50 day moving average price is $60.87 and its 200-day moving average price is $60.74. Corteva, Inc. has a 1 year low of $50.01 and a 1 year high of $67.93. The firm has a market capitalization of $46.24 billion, a price-to-earnings ratio of 52.48, a price-to-earnings-growth ratio of 1.68 and a beta of 0.72. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.45 and a quick ratio of 0.93.

Corteva (NYSE:CTVA - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.88 by $0.25. The business had revenue of $4.42 billion for the quarter, compared to analyst estimates of $4.56 billion. Corteva had a net margin of 5.36% and a return on equity of 7.19%. The company's revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.89 earnings per share. On average, equities research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Friday, May 2nd will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend is Monday, June 2nd. Corteva's dividend payout ratio is presently 41.46%.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on CTVA. Bank of America upped their target price on Corteva from $69.00 to $73.00 and gave the company a "buy" rating in a research report on Tuesday, February 11th. UBS Group raised their price objective on Corteva from $74.00 to $76.00 and gave the stock a "buy" rating in a research note on Thursday. Morgan Stanley lifted their target price on Corteva from $65.00 to $71.00 and gave the stock an "overweight" rating in a report on Friday. BNP Paribas raised shares of Corteva to a "hold" rating in a research report on Monday, February 10th. Finally, Oppenheimer restated an "outperform" rating and set a $75.00 price objective (up from $72.00) on shares of Corteva in a research note on Friday. One research analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, Corteva currently has an average rating of "Moderate Buy" and an average target price of $69.64.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.